Skip to main content
RNL23 Replays (5.6.2023)

This week on the podcast we feature replay content from RNL 2023, cannabis effects on pain an

Dr. John Cush RheumNow

3 years 3 months ago
RNL23 Replays (5.6.2023) This week on the podcast we feature replay content from RNL 2023, cannabis effects on pain and sleep, and what drives PJP risk the most - steroids or RTX? https://t.co/hmJQBq3krb https://t.co/xeh0gOqoTf
Downs Syndrome (1/700) & autoimmune mechanisms - Downs has a 4-6 fold higher risk of JIA, type 1 diabetes, autoimmun

Dr. John Cush RheumNow

3 years 3 months ago
Downs Syndrome (1/700) & autoimmune mechanisms - Downs has a 4-6 fold higher risk of JIA, type 1 diabetes, autoimmune thyroid disease and coeliac disease. https://t.co/wVUDRCS96I https://t.co/RosPAkRnPA
Thanks to these Rheumatology Influencers who were tweeting & teaching from RheumNow Live 2023!

Look for all the RNL

Dr. John Cush RheumNow

3 years 3 months ago
Thanks to these Rheumatology Influencers who were tweeting & teaching from RheumNow Live 2023! Look for all the RNL23 Replays this month- videos, podcasts, articles, & tweets @ericdeinmd @doctorRBC @NoufAhmedAlham2 @Janetbirdope @uptoTate @anisha_dua @DrLauraCoates https://t.co/AgvQ06dp3Z
in 2022 COVID slid from the #3 to the #4 cause of death in USA, accounting for nearly a quarter million deaths, a 47 per

Dr. John Cush RheumNow

3 years 3 months ago
in 2022 COVID slid from the #3 to the #4 cause of death in USA, accounting for nearly a quarter million deaths, a 47 percent decrease from the 462,193 Covid-related deaths in 2021. Most COVID deaths occured in the first few mos of 2022 https://t.co/qervCp0P87 https://t.co/WN7DvsFhNC
Prevalence and Mortality of IgG4-related disease in the USA

A review of the epidemiology of IgG4-RD in the USA shows a

Dr. John Cush RheumNow

3 years 3 months ago
Prevalence and Mortality of IgG4-related disease in the USA A review of the epidemiology of IgG4-RD in the USA shows a low prevalence with possibly increasing numbers, owing to increasing awareness of this unique immune-mediated condition. https://t.co/umWCPX4ing https://t.co/ZIButYrtp0
Romosuzumab and Low Sclerostin Levels Underlie CV Risk

New research highlights potential safety concerns around women

Dr. John Cush RheumNow

3 years 3 months ago
Romosuzumab and Low Sclerostin Levels Underlie CV Risk New research highlights potential safety concerns around women taking romosozumab, a new anti-osteoporosis drug available on the NHS. https://t.co/tRGOXrm0Fk https://t.co/ebiRpCC81p
Contratulations to Dr Germain Honvo (Univ. of Abomey-Calavi, Univ. Liège/Belgium) in receiving the 2023 Pierre Meunier

Dr. John Cush RheumNow

3 years 3 months ago
Contratulations to Dr Germain Honvo (Univ. of Abomey-Calavi, Univ. Liège/Belgium) in receiving the 2023 Pierre Meunier Young Scientist Award from ESCEO & the International Osteoporosis Foundation (IOF) for his work in osteoarthritis, aging & locomotion https://t.co/gOB6VfP9vn https://t.co/SBbexkty4F
Clinical overview of subacromial pain syndr (SAPS) Brit J Sports Med. SAPS has heterogeneous causes; Dx by physical exa

Dr. John Cush RheumNow

3 years 3 months ago
Clinical overview of subacromial pain syndr (SAPS) Brit J Sports Med. SAPS has heterogeneous causes; Dx by physical examination and imaging. Need to exclude glenohumeral OA, frozen shoulder, GH instability, rotator cuff tears, neuro & cervical disorders https://t.co/d77kXa2qSi https://t.co/vBF0692huh
Remission in Psoriatic Arthritis
DDW 2023 study claims microscopic colitis (MC) pts had a 2fold higher risk of #RA. 11,293 MC pts matched 1:5 w/ populati

Dr. John Cush RheumNow

3 years 3 months ago
DDW 2023 study claims microscopic colitis (MC) pts had a 2fold higher risk of #RA. 11,293 MC pts matched 1:5 w/ population controls. With 8 yrs of F/U, RA was found in 1.1% of MC vs 0.6% controls (adj HR 1.92 (95% CI = 1.56-2.34). https://t.co/R5faYDoaAq https://t.co/qiaOMgOyLR
Dr. Christina Chambers, an epidemiologist at the University of California San Diego and the principal investigator of MotherToBaby Pregnancy Studies, reviewed the available data on psoriatic arthritis and pregnancy. There is little evidence at this time that pregnancy affects PsA, though studies reliably demonstrate increase in disease activity in the post-partum period in both skin and joint disease.
REMIT-UC: Tofacitinib study 334 w/ Ulcerative Colitis:Clinical remission in 35%, Endoscopic remission in ~24%; & low

Dr. John Cush RheumNow

3 years 3 months ago
REMIT-UC: Tofacitinib study 334 w/ Ulcerative Colitis:Clinical remission in 35%, Endoscopic remission in ~24%; & low risk (per/100PY) of serious infections (2.1), H zoster (0.5), & VTE (1.1). Loss of response in 45%, but recaptured 55% w/ dose escalation https://t.co/OgQYcq9pQk https://t.co/1KtLDvkQGT
BMJ Systematic review of OP trials (69 RCTs, >80k pts) & Fx rates in postmenopausal F shows protective effect of

Dr. John Cush RheumNow

3 years 3 months ago
BMJ Systematic review of OP trials (69 RCTs, >80k pts) & Fx rates in postmenopausal F shows protective effect of bisphosphonates, PTH receptor agonists, & romosozumab vs PBO. Most effective PTHra > ROMO > Denosumab > bisphosphonates > PBO https://t.co/wKVCUnjmNT MJ
×